Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01466621 · ClinicalTrials.gov registry record
Response to Cardiac Resynchronization Therapy of Previously Right Ventricular Paced Heart Failure Patients
A clinical trial, sponsored by Allina Health System.
- Completed
- Registry status
- 743
- Enrollment target
NCT01466621: Completed study, sponsored by Allina Health System.
NCT01466621 is a clinical trial that has completed, run by Allina Health System. The registered enrollment target is 743 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01466621 has completed, sponsored by Allina Health System.
- COMPLETED
- Registry status
- 743 participants
- Enrollment target
Study Summary
The present proposal is designed to investigate the response to CRT in patients who were previously paced from the right ventricle (RV). The negative physiologic and structural changes associated with chronic RV pacing are well documented, but patient response following upgrade to CRT after chronic RV pacing has not been well characterized in a large cohort.
Primary Outcome
Retrospectively measure the time in days from device implant to death, if applicable.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 743 participants |
| Start Date | 2011-10 |
| Est. Completion | 2014-06 |
What the finished NCT01466621 record still lists
NCT01466621 is an observational study that tracks outcomes without assigning an intervention. The registered 743 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01466621 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01466621 about?
NCT01466621 is a clinical study titled "Response to Cardiac Resynchronization Therapy of Previously Right Ventricular Paced Heart Failure Patients". The present proposal is designed to investigate the response to CRT in patients who were previously paced from the right ventricle (RV). The negative physiologic and structural changes associated with chronic RV pacing are well documented, but patient response following upgrade to CRT after chronic ...
What is the current status of trial NCT01466621?
This trial is currently completed. The enrollment target is 743 participants. The study started on 2011-10. Estimated completion is 2014-06.
Who is sponsoring clinical trial NCT01466621?
This trial is sponsored by Allina Health System, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05619185 · 744 participants · NA
A SMART Evaluation of an Adaptive Web-based AUD Treatment for Service Members and Their Partners
- NCT06417814 · 744 participants · Phase 3
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- NCT07046351 · 744 participants · NA
weSIPsmarter: Evaluating a Digital Health Intervention Aimed at Reducing Sugary Drinks Among Rural Head Start Preschoolers and Their Parents
- NCT07199569 · 744 participants · Phase 2
Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production Cells
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia